At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 155 target
Drug / intervention
Communicationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy
In Brief
A clinical study evaluating Communication for Advanced Cancer. Currently recruiting, targeting 155 participants across 1 site.
Detailed Summary
To develop an educational patient decision aid for advanced cancer patients to prepare them to have conversations with their clinicians about treatment options (Treatments in Advanced cancer - Decision Aid, TA-DA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdvanced Cancer
CountriesUnited States
Collaborators--
Timeline
N/ARecruiting
20262027202820292030
First PostedJun 2025
Enrollment StartJul 2025
TodayJul 2026
Primary CompletionJul 2028
Study CompletionJul 2030
First PostedJun 8, 2025
Enrollment StartJul 10, 2025
Primary CompletionJul 31, 2028
Study CompletionJul 31, 2030
TodayJul 1, 2026
Enrollment to primary: 3.1 yearsPosted 1.1 years agoPrimary completion in 2.1 years
Interventions
Communicationother
Participants meet with clinician